SARS-CoV-2 Ag Rapid Test
EBS SARS-CoV-2 Ag Rapid Test
(20 tests)
Detection of Nucleocapsid-Antigen
Nasopharynx (NP) smear sample
10 minutes to result
Diagn. Sensitivity: 95.7 %
Diagn. Specificity: 99,1%
Detailed information
RT-PCR-Kits (2019-nCOV)
Extraction and Extraction-free Procedures
EurobioPlex SARS-CoV-2 Variants, Detection & Typing
(96 reactions, 46 patient samples)
SARS-CoV-2 variants: Detection of UK variant B1.1.7; SA variant B1.351; BR/JP variant P1 and BR/JP variant P2
Detailed information
RAQ SARS-CoV-2 Multiplex
(100 reactions)
Sample treatment: 10 min. at 99°C
Detailed information
RAQ Flu/COVID-19 PCR Kit
(50 reactions)
Differentiation between Flu A, Flu B and SARS-CoV-2
Sample treatment: 10 min. at 99°C
Detailed information
EurobioPlex SARS-CoV-2 Multiplex
(192 reactions)
Licenced from Institut Pasteur
Validated on saliva samples
Detailed information
Serological Tests
EDI COVID-19 Nucleocapsid IgG Quantitative ELISA
IgG concentration instead of OD values
5 IgG Calibrators
Detailed information
EDI Quantitative SARS-CoV-2 Spike Protein IgG ELISA Kit
For specific monitoring of successful vaccination and qualification of convalescent plasma donors
Detailed information
2019-nCoV IgG/IgM Rapid Test
(40 Tests)
SARS-CoV-2 Nucleocapsid
SARS-CoV-2 Spike protein
Serum, Plasma, Whole Blood
10 minutes to result
Succesfully evaluated in different international studies
Detailed information
SARS-CoV-2 Inhibition Tests
SARS-CoV-2 Neutralization Antibody ELISA
Specific and quantitative determination of the inhibitory effects from neutralizing antibodies on recombinant receptor binding domaine (RBD) of SARS-CoV-2;
Sample material: Serum and plasma
Detailed information
SARS-CoV-2 Neutralization Antibody Rapid Test
Specific and qualititative detection of the inhibitory effects from neutralizing antibodies on recombinant receptor binding domaine (RBD) of SARS-CoV-2;
Sample material: Serum and plasma
Results in 20 minutes
Coming soon
